Management of Hemarthrosis

D. Green, F. R. Schmid

Research output: Contribution to journalLetter

2 Citations (Scopus)

Abstract

To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.

Original languageEnglish (US)
Pages (from-to)1212-1213
Number of pages2
JournalNew England Journal of Medicine
Volume282
Issue number21
DOIs
StatePublished - May 21 1970

Fingerprint

Hemarthrosis
Adrenal Cortex Hormones
Joints
Hemophilia A
Hemorrhage
Pain
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Green, D. ; Schmid, F. R. / Management of Hemarthrosis. In: New England Journal of Medicine. 1970 ; Vol. 282, No. 21. pp. 1212-1213.
@article{54c89f25e2c5401283f105aeb3775eb1,
title = "Management of Hemarthrosis",
abstract = "To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.",
author = "D. Green and Schmid, {F. R.}",
year = "1970",
month = "5",
day = "21",
doi = "10.1056/NEJM197005212822123",
language = "English (US)",
volume = "282",
pages = "1212--1213",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "21",

}

Management of Hemarthrosis. / Green, D.; Schmid, F. R.

In: New England Journal of Medicine, Vol. 282, No. 21, 21.05.1970, p. 1212-1213.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Management of Hemarthrosis

AU - Green, D.

AU - Schmid, F. R.

PY - 1970/5/21

Y1 - 1970/5/21

N2 - To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.

AB - To the Editor: Kisker and Burke (N.E.J.M. 282:639–642, 1970) advocate the use of oral corticosteroids on a short-term basis in the treatment of the hemarthrosis of hemophilia. We are concerned about two aspects of their study. The first is the fact that they based their decision on the amount of blood-fraction replacement therapy required by the patient on their clinical evaluation of the affected joint. Decrease in pain and increase in motion in the patients treated with corticosteroids was equated with reduction of bleeding into the joint, an assumption that requires proof. In our experience, particularly with recurrent hemarthrosis, small.

UR - http://www.scopus.com/inward/record.url?scp=0014957599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014957599&partnerID=8YFLogxK

U2 - 10.1056/NEJM197005212822123

DO - 10.1056/NEJM197005212822123

M3 - Letter

C2 - 5440065

AN - SCOPUS:0014957599

VL - 282

SP - 1212

EP - 1213

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -